União Europeia - alemão - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

União Europeia - alemão - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).

Bélgica - alemão - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare - dutasteride; tamsulosin hydrochloride - hartkapsel - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

Bélgica - alemão - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - dutasteride; tamsulosin hydrochloride - hartkapsel - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

Bélgica - alemão - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - dutasteride; tamsulosin hydrochloride - hartkapsel - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

Bélgica - alemão - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo - dutasteride; tamsulosin hydrochloride - hartkapsel - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

Bélgica - alemão - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mylan - dutasteride; tamsulosin hydrochloride - hartkapsel - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

Bélgica - alemão - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva - dutasteride; tamsulosin hydrochloride - hartkapsel - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

Bélgica - alemão - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - dutasteride; tamsulosin hydrochloride - hartkapsel - 0,5 mg - 0,4 mg - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin and dutasteride

União Europeia - alemão - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.